Companies: 10,795·Total market cap: $144.5T
LianBio

LianBio

LIANYOTCHealthcare● Active
$0.11
+$0.00(+0.00%)
Market Cap$12025709
P/E Ratio—
52W High$0.439
52W Low$0.03
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

LianBio (LIANY) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LIANY · as of Jun 9, 2026

Key Statistics

EPS (TTM)$2.92liany eps ttm · liany earnings per shareEarnings history
PE Ratio (TTM)0.0×liany pe ratio ttm · liany price to earningsPE Ratio deep dive
Revenue (TTM)0.00liany revenue ttm · liany annual revenueFull revenue history
Dividend Yield955.56%does liany pay dividends · liany dividend yieldDividend history
Shares Outstanding109.1Mliany shares outstanding · liany floatShares outstanding history
Next EarningsAug 18, 2026Est.liany earnings date · liany next earningsEarnings history

Explore LianBio Data

liany stock data · financials
Market Cap$12.0Mliany market cap · liany valuation
Analyst Forecast$— · Buy
Dividends955.56%does lianbio pay dividends · liany dividend yield
Revenue—lianbio annual revenue · liany revenue
EarningsEPS $0.04+96.51%liany earnings · liany eps
PE Ratio0.0×liany pe ratio · liany price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
lianbio revenue · liany revenue 2025
FY 2025Net Income$4.9M▲ +98.32% YoY
202320242025
lianbio net income · liany profit 2025
FY 2025EPS$0.04▲ +96.51% YoY
202320242025
liany eps · lianbio earnings per share 2025
TTM:Revenue: $0.00Net Income: $314.0MEPS: $2.92View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy3 analystsis liany a buy · liany analyst rating
Strong Buy
0
Buy
1
Hold
1
Sell
1
Strong Sell
0
12-Month Price Target
$—Low
$0.11Current
$—Avg Target
$—High
liany price target · liany 12 month forecast

Total: 3 · Buy rate: 33.3%

Stock Performance

Full History
1D+0.00%
1W-8.17%
1M-21.29%
3M+21.10%
YTD+16.00%
1Y-70.22%
5Y-99.20%

About LianBio

CEOAdam Leo Stone
IPO DateNov 1, 2021
Employees163
CountryUS
Websitelianbio.com

LianBio is a biopharmaceutical firm dedicated to advancing and marketing therapeutic agents across various critical health sectors, including cardiovascular disorders, oncology, ophthalmological condi…

BiotechnologyHealthcareOTCUS

what is lianbio · liany stock overview · lianbio company profile · who is lianbio ceo · liany OTC · lianbio headquarters · lianbio business segments

About Stock Overview & Key Data

LianBio (LIANY) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 1, 2021. As of the latest trading session, LIANY stock price is $0.11, with a market capitalization of $12.0M. The stock has returned -70.22% over the past 12 months and +16.00% year-to-date.

According to 3 Wall Street analysts, the consensus rating for LianBio stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, LianBio reported revenue of — and net income of $4.9M. For detailed data — including LianBio revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, LianBio (LIANY) stock price is $0.11. The stock is traded on OTC under the ticker symbol LIANY. The 52-week range is $0.03 – $0.44.

LIANY stock priceLIANY quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice